{"filings":[{"id":67963,"accession_number":"0001516513-26-000017","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2026-05-13T20:04:36+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Doximity Q4 GAAP net income sinks 69%; guides ~4% FY2027 revenue growth; new CFO and President","event_type":"earnings","confidence":"high","bullets":["FY2026 revenue $644.9M (+13% YoY); GAAP net income $196.1M (down 12% YoY, margin 30.4%).","Q4 revenue $145.4M (+5% YoY); GAAP net income $19.1M (down 69% YoY, margin 13.1%).","Non-GAAP diluted EPS $0.26 (Q4) vs $0.38 YoY; FY2026 non-GAAP EPS $1.52 vs $1.42.","Guidance: Q1 rev $151-152M; FY2027 rev $664-676M (~4% YoY growth), adj. EBITDA $323-335M.","Appointed Matthew Sonefeldt as CFO (base $400K, $12M RSUs) and Dr. Steven Zatz as President (base $400K, $2.7M RSUs)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93329,"accession_number":"0001516513-26-000014","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2026-04-17T23:59:59+00:00","items":["5.02","7.01"],"status":"ready","headline":"Doximity CFO Anna Bryson resigns; interim CFO continues; guidance reaffirmed","event_type":"leadership","confidence":"high","bullets":["Anna Bryson's resignation as CFO accepted April 13, 2026, following medical leave since Feb 5, 2026.","Siddharth Sitaram (CAO) serves as interim principal financial and accounting officer effective Feb 3, 2026.","Company reaffirms Q4 and FY2026 guidance originally provided on Feb 5, 2026 earnings release.","CFO search ongoing; update expected on next earnings call."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104874,"accession_number":"0001516513-26-000004","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Doximity Q3 revenue up 10% to $185M, guides Q4 $143-144M, authorizes $500M buyback","event_type":"earnings","confidence":"high","bullets":["Revenue $185.1M (+10% YoY); net income $61.6M (33% margin) vs $75.2M (45% margin) YoY.","Adjusted EBITDA $111.4M (60% margin), up 9% YoY; non-GAAP diluted EPS $0.46 vs $0.45.","Q4 guidance: revenue $143-144M, adj EBITDA $63.5-64.5M; FY2026 rev $642.5-643.5M.","Board authorizes new $500M stock repurchase program with no expiration date.","CFO Anna Bryson on temporary medical leave; CAO Siddharth Sitaram named interim principal financial officer."],"consensus_eps_estimate":null,"consensus_eps_actual":0.88,"consensus_revenue_estimate":null,"consensus_revenue_actual":499491000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121132,"accession_number":"0001516513-25-000114","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-12-30T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Doximity agrees to $31M settlement to resolve securities class action","event_type":"litigation","confidence":"high","bullets":["Settlement payment of $31 million fully funded by insurance proceeds; no admission of liability.","Parties entered into Agreement of Settlement on Dec 24, 2025, subject to court approval and stockholder notice.","Lawsuit is In re Doximity, Inc. Securities Litigation, No. 5:24-cv-02281 (N.D. Cal.).","Dismissal of all claims against company and named individuals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121131,"accession_number":"0001516513-25-000110","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity reports Q2 revenue $168.5M (+23% YoY), adjusted EBITDA $100.8M; raises FY guidance","event_type":"earnings","confidence":"high","bullets":["Revenue $168.5M vs $136.8M YoY, up 23%; non-GAAP net income $90.0M (53.4% margin).","Diluted EPS $0.31; non-GAAP diluted EPS $0.45 (vs $0.30). Operating cash flow $93.9M, up 37%.","Record 650K prescribers used workflow tools; AI Scribe and DoxGPT users grew >50% QoQ.","Q3 guidance: rev $180-181M, adj. EBITDA $103-104M. FY2026 updated: rev $640-646M, adj. EBITDA $351-357M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.57,"consensus_revenue_estimate":null,"consensus_revenue_actual":314438000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137777,"accession_number":"0001516513-25-000104","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-09-02T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Doximity shareholders elect two Class I directors, ratify auditor, approve say-on-pay at 2025 annual meeting","event_type":"other","confidence":"high","bullets":["Jeff Tangney and Kira Wampler elected as Class I directors to serve until 2028 annual meeting.","Ratification of Deloitte & Touche as independent auditor for FY2026 approved with 629,220,010 votes for.","Non-binding advisory vote on named executive officer compensation approved with 589,323,535 votes for.","Shareholder present represented 97.51% of eligible votes, constituting a quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137776,"accession_number":"0001516513-25-000097","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-08-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Doximity GC Jennifer Chaloemtiarana to step down; John Vaughan named replacement","event_type":"leadership","confidence":"high","bullets":["Jennifer Chaloemtiarana steps down as General Counsel, Corporate Secretary, and Chief Compliance Officer effective August 29, 2025.","John Vaughan will assume all three roles on the same date.","Chaloemtiarana will remain in an advisory capacity through November 17, 2025, then receive post-employment benefits per August 2020 offer letter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137775,"accession_number":"0001516513-25-000092","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q1 revenue $145.9M (+15%), adj. EBITDA $79.8M (+21%), raises FY guidance","event_type":"earnings","confidence":"high","bullets":["Revenue $145.9M (+15% YoY); net income $53.3M (36.5% margin); non-GAAP EPS $0.36.","Adjusted EBITDA $79.8M (+21% YoY), margin 54.7%; operating cash flow $62.1M (+51%).","FY2026 guidance raised: revenue $628M-$636M, adj. EBITDA $341M-$349M.","AI suite fastest growing, up 5x YoY; over 630K prescribers used workflow tools.","Acquired Pathway Medical (details in separate release)."],"consensus_eps_estimate":0.2888,"consensus_eps_actual":0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":145913000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155162,"accession_number":"0001516513-25-000065","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-06-13T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Doximity co-founder Dr. Nathan Gross steps down as CSO, stays as advisor","event_type":"leadership","confidence":"high","bullets":["Dr. Gross transitions from Chief Strategy Officer to advisor effective June 16, 2025.","No cash compensation for advisory role; RSU & option awards continue vesting through September 2025.","Gross co-founded Doximity in 2010 and served as CSO; advisory agreement filed later.","Blog post from CEO Tangney thanks Gross for 15 years; Gross cites 'bittersweet' decision."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}